What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Mutation
His primary scientific interests are in Epilepsy, Anesthesia, Pediatrics, Genetics and Dravet syndrome.
His Epilepsy research incorporates themes from Electroencephalography, Mutation, Generalized epilepsy with febrile seizures plus, Age of onset and Cohort.
His Anesthesia study incorporates themes from Clinical trial, Tolerability, Adverse effect, Retrospective cohort study and Symptomatic generalised epilepsy.
His Pediatrics study integrates concerns from other disciplines, such as Hydrocortisone, Prednisone, Dexamethasone and Landau–Kleffner syndrome.
His research investigates the connection between Genetics and topics such as Molecular biology that intersect with issues in Subtelomere, Multiplex and Chromosome.
Berten Ceulemans combines subjects such as Missense mutation and Myoclonic epilepsy with his study of Dravet syndrome.
His most cited work include:
- De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. (924 citations)
- KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. (309 citations)
- Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. (219 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Epilepsy, Pediatrics, Genetics, Dravet syndrome and Anesthesia.
The study incorporates disciplines such as Missense mutation, Physical medicine and rehabilitation and Electroencephalography in addition to Epilepsy.
The concepts of his Pediatrics study are interwoven with issues in Status epilepticus, Retrospective cohort study, Disease, Cohort and Migraine.
His research integrates issues of Molecular biology and Autism in his study of Genetics.
His Dravet syndrome research includes elements of Epilepsy syndromes, Prospective cohort study, Pulmonary hypertension and Myoclonic epilepsy.
Berten Ceulemans has researched Anesthesia in several fields, including Tolerability, Adverse effect, Childhood epilepsy and Refractory epilepsy.
He most often published in these fields:
- Epilepsy (34.67%)
- Pediatrics (27.64%)
- Genetics (18.09%)
What were the highlights of his more recent work (between 2018-2021)?
- Epilepsy (34.67%)
- Dravet syndrome (14.57%)
- Genetics (18.09%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Epilepsy, Dravet syndrome, Genetics, Missense mutation and Pediatrics.
Berten Ceulemans performs multidisciplinary study on Epilepsy and In patient in his works.
His study in Dravet syndrome is interdisciplinary in nature, drawing from both Photosensitive epilepsy, Randomized controlled trial, Intention-to-treat analysis and Placebo-controlled study.
His work deals with themes such as Loss function, Polymicrogyria, Bioinformatics, Intellectual disability and Haploinsufficiency, which intersect with Missense mutation.
His Pediatrics research is multidisciplinary, incorporating elements of Text mining, Magnetic resonance imaging, Facial nerve and Temporal bone.
His Pathology research is multidisciplinary, relying on both Myoclonus, Status epilepticus and SCN1B.
Between 2018 and 2021, his most popular works were:
- Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial (57 citations)
- Diagnostic implications of genetic copy number variation in epilepsy plus (25 citations)
- IQSEC2-related encephalopathy in males and females : a comparative study including 37 novel patients (22 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Mutation
His main research concerns Epilepsy, Dravet syndrome, Genetics, Internal medicine and Anesthesia.
He mostly deals with Epileptic spasms in his studies of Epilepsy.
His Dravet syndrome study combines topics in areas such as Status epilepticus, Proband, Myoclonus and Pathology.
Phenotype, Genome, GENCODE, Gene and Exome are the primary areas of interest in his Genetics study.
His Internal medicine research integrates issues from Immunoglobulin E, Antibody and Endocrinology.
His Anesthesia research incorporates elements of Photosensitive epilepsy, Randomized controlled trial, Intention-to-treat analysis and Placebo-controlled study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
